Modeling high-risk Wilms tumors enables the discovery of therapeutic vulnerability

Gui Ma(University of Wisconsin Carbone Cancer Center), Wei Xu(University of Wisconsin–Madison)

Cell Reports Medicine

October 1, 2024

10.1016/j.xcrm.2024.101770

Cited by 6

Related Papers

Global mapping of CARM1 substrates defines enzyme specificity and substrate recognition

|Nature Communications|2017|138

Systematic Analyses of the Cytotoxic Effects of Compound 11a, a Putative Synthetic Agonist of Photoreceptor-Specific Nuclear Receptor (PNR), in Cancer Cell Lines

|PLoS ONE|2013|12

<scp><i>NEAT1</i></scp> repression by <scp>MED12</scp> creates chemosensitivity in p53 wild‐type breast cancer cells

|FEBS Journal|2024|6

Transcriptional elongation machinery controls vulnerability of breast cancer cells to PRC2 inhibitors

|bioRxiv (Cold Spring Harbor Laboratory)|2020|0